Device makers settle with prosecutors

Five medical device makers are crying uncle to avoid federal prosecution in a kickback case. To induce surgeons to use their orthopedic implants, the companies allegedly forked over tens, even hundreds, of thousands a year in consulting fees, trips, and other perks. Zimmer Holdings, Johnson & Johnson's DuPuy Orthopedics, Smith & Nephew, and Biomet will pay a total of about $310 million and submit to government monitoring and other reforms. Stryker, which cooperated with prosecutors early on, won't pay any civil settlement, but it has agreed to the reforms.

This doctor-payment deal is just the latest in a series of settlements, prosecutions, investigations and the like. The "reforms" basically entail doctors disclosing any "consulting deals" to their patients. Legislation now pending in Congress would require companies to fess up to any doctor payments. So we may soon see a lot more sunshine in this previously murky area.

- read the article in the Los Angeles Times

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

THIS WEEK: Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today!

Suggested Articles

The new Community trial will first test Amgen's Otezla, Takeda's Takhzyro and UCB's zilucoplan in hospitalized patients.

Indivior faces a new lawsuit from RB, its former parent company, over a scheme to market opioid addiction therapy Suboxone Film.

A new FDA effort brings cancer drug labels to life in videotaped panels with experts, debuting its first episode on Seagen's MBC med Tukysa.